Carol Greve-Phillips | Strategic Advisory Board Member
Atlantic Research Group Inc

Carol Greve-Phillips, Strategic Advisory Board Member, Atlantic Research Group Inc

Carol is an experienced rare disease biotech executive with a strong track record of building, developing and assisting orphan businesses through strategic planning, direct sales and commercial and business development transactions. Carol was most recently the Head of Business Development and Strategy for Spark Therapeutics (Gene Therapy) and spent 15 years of her career with Genzyme Corporation as a Vice President Corporate Development and led cross-functional Orphan and Rare Disease team members in identifying and targeting complex rare disease products. Carol is also an active member of the Harvard Business School Leadership Training Program.

back to speakers